Adult-onset Still's disease complicated with macrophage activation syndrome: A case report

<p>Adult-onset Still's disease is a rare systemic disease while macrophage activation syndrome is a fulminant complication of Still's disease. As mortality is high in macrophage activation syndrome, prompt diagnosis is crucial to commence definitive management. Adult-onset Still'...

Full description

Saved in:
Bibliographic Details
Main Authors: MNSK Perera (Author), A Gunapala (Author)
Format: Book
Published: Journal of Vaccines and Immunology - Peertechz Publications, 2022-07-23.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_jvi_000051
042 |a dc 
100 1 0 |a MNSK Perera  |e author 
700 1 0 |a A Gunapala  |e author 
245 0 0 |a Adult-onset Still's disease complicated with macrophage activation syndrome: A case report 
260 |b Journal of Vaccines and Immunology - Peertechz Publications,   |c 2022-07-23. 
520 |a <p>Adult-onset Still's disease is a rare systemic disease while macrophage activation syndrome is a fulminant complication of Still's disease. As mortality is high in macrophage activation syndrome, prompt diagnosis is crucial to commence definitive management. Adult-onset Still's disease is a rare systemic disease while macrophage activation syndrome is a fulminant complication of Still's disease. As mortality is high in macrophage activation syndrome, prompt diagnosis is crucial to commence definitive management. Macrophage activation syndrome is a complication of adult-onset Still's disease. When first-line immunosuppressives fail, second-line medications including biologic therapy can be considered with good results. </p> 
540 |a Copyright © MNSK Perera et al. 
546 |a en 
655 7 |a Case Report  |2 local 
856 4 1 |u https://doi.org/10.17352/jvi.000051  |z Connect to this object online.